2-methyl-1-[(E)-pent-3-enyl]-3-(1-propylpiperidin-4-yl)guanidine
C15H30N4 — CID 111791613
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-methyl-1-[(E)-pent-3-enyl]-3-(1-propylpiperidin-4-yl)guanidine
2-methyl-1-[(E)-pent-3-enyl]-3-(1-propylpiperidin-4-yl)guanidine (PubChem CID 111791613) has the molecular formula C15H30N4 and a molecular weight of 266.43 g/mol. Its IUPAC name is 2-methyl-1-[(E)-pent-3-enyl]-3-(1-propylpiperidin-4-yl)guanidine.
Molecular Properties
| Compound Name | 2-methyl-1-[(E)-pent-3-enyl]-3-(1-propylpiperidin-4-yl)guanidine |
|---|---|
| PubChem CID | 111791613 |
| Molecular Formula | C15H30N4 |
| Molecular Weight | 266.43 g/mol |
| Exact Mass | 266.25 |
| IUPAC Name | 2-methyl-1-[(E)-pent-3-enyl]-3-(1-propylpiperidin-4-yl)guanidine |
| SMILES | C/C=C/CCN/C(=N\C)NC1CCN(CCC)CC1 |
| InChI | InChI=1S/C15H30N4/c1-4-6-7-10-17-15(16-3)18-14-8-12-19(11-5-2)13-9-14/h4,6,14H,5,7-13H2,1-3H3,(H2,16,17,18)/b6-4+ |
| InChIKey | HKAUFOBZKSHBRZ-GQCTYLIASA-N |
| XLogP | 1.99 |
| TPSA | 39.66 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 19 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 266.43 |
| LogP ≤ 5 | 1.99 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 111791613 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.